SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-021665
Filing Date
2024-05-08
Accepted
2024-05-08 16:08:19
Documents
15
Period of Report
2024-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pcvx-20240508.htm   iXBRL 8-K 26776
2 EX-99.1 pcvx-20240508xexx991.htm EX-99.1 67798
6 img251305552_0.jpg GRAPHIC 9918
  Complete submission text file 0001628280-24-021665.txt   245749

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcvx-20240508.xsd EX-101.SCH 1901
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcvx-20240508_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcvx-20240508_pre.xml EX-101.PRE 13046
18 EXTRACTED XBRL INSTANCE DOCUMENT pcvx-20240508_htm.xml XML 2811
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39323 | Film No.: 24926023
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)